Clinical Trial: Phase II clinical study of irinotecan liposome combined with 5-FU/LV, targeted therpy and enlonstobart as first-line treatment for metastatic colorectal cancer (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase II clinical study of irinotecan liposome combined with 5-FU/LV, targeted therpy and enlonstobart as first-line treatment for metastatic colorectal cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132938

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: Shanxi Provincel Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337598

Published by HT Digital Content Services with permission from Health Daily Digest....